CTCBIO Inc. (KOSDAQ:060590)
6,700.00
+350.00 (5.51%)
At close: Aug 13, 2025, 3:30 PM KST
CTCBIO Revenue
CTCBIO had revenue of 34.10B KRW in the quarter ending March 31, 2025, with 2.72% growth. This brings the company's revenue in the last twelve months to 145.31B, up 6.98% year-over-year. In the year 2024, CTCBIO had annual revenue of 144.41B with 4.74% growth.
Revenue (ttm)
145.31B
Revenue Growth
+6.98%
P/S Ratio
1.10
Revenue / Employee
593.11M
Employees
245
Market Cap
160.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 144.41B | 6.53B | 4.74% |
Dec 31, 2023 | 137.88B | -27.33B | -16.54% |
Dec 31, 2022 | 165.21B | 24.89B | 17.74% |
Dec 31, 2021 | 140.32B | 10.29B | 7.91% |
Dec 31, 2020 | 130.03B | -6.09B | -4.48% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.76T |
Samsung Biologics | 4,898.69B |
Hyundai Motor Company | 178.98T |
Hanwha Aerospace | 15.28T |
Doosan Enerbility | 15.88T |
KB Financial Group | 15.69T |